Showing results (1191-1200 of 1,217) with videos related to

Sort By:
Pageof 122
Kidney International Reports|November 13, 2024
Kidney Beam-A Cost-Effective Digital Intervention to Improve Mental HealthSharlene A Greenwood, Juliet Briggs, Christy Walklin, et al.
Cladistics : the International Journal of the Willi Hennig Society|June 24, 2025
The phylogenetic relationships of Bokermann´s treefrogs: species groups, reproductive biology, and biogeography (Anura: Hylidae: Bokermannohyla)Julian Faivovich, Ana Carolina C Lourenço, Paulo D P Pinheiro, et al.
Stroke|May 22, 2025
Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS TrialPhilip S Nash, Hakim-Moulay Dehbi, Norin Ahmed, et al.
Nature Medicine|September 5, 2025
Feasibility and clinical utility of expanded genomic newborn screening in the Early Check programHeidi L Cope, Elizabeth R Jalazo, Jonathan S Berg, et al.
JAMA|November 7, 2025
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-AnalysisBrendon L Neuen, Robert A Fletcher, Stefan D Anker, et al.
Circulation|April 7, 2024
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-AnalysisSiddharth M Patel, Yu Mi Kang, KyungAh Im, et al.
The Lancet. Digital Health|November 15, 2023
Evaluating the effect of a digital health intervention to enhance physical activity in people with chronic kidney disease (Kidney BEAM): a multicentre, randomised controlled trial in the UKSharlene A Greenwood, Hannah M L Young, Juliet Briggs, et al.
American Journal of Nephrology|February 9, 2026
Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) TrialSunil V Badve, Maha Al Ammari, Craig S Anderson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2020
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristicsDavid C Wheeler, Bergur V Stefansson, Mikhail Batiushin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 24, 2025
A Core Outcome Set for Trials in CKD: Report of the Standardized Outcomes in Nephrology-Chronic Kidney Disease (SONG-CKD) Stakeholder WorkshopsAndrea Matus Gonzalez, Rosanna Cazzolli, Magdalena Madero, et al.
Pageof 122